Skip to main content

Fiscal Wizard · Single-issue tearsheet

NSRX / Jun 22, 2026 Run #7666

NSRX

Nasus Pharma Ltd.

Nasus Pharma Ltd., a clinical-stage specialty pharmaceutical company focused on the development of intranasal drugs to treat emergency medical conditions. It offers Powder-Based Intranasal (PBI) products to address acute medical conditions and public health threats. The company's products include NS002, Intranasal Epinephrine for assisting in severe allergic reaction emergency situations and NS001, an Intranasal Naloxone powder nasal spray for the treatment of opioid overdose. Nasus Pharma Ltd. was incorporated in 2019 and is based in Tel Aviv-Yafo, Israel.

Composite verdict

F 3.0 / 100
Bearish setup · Reversal 7 drivers · 2 gates blocking
  • Rate of Change
  • Declining Volume
  • Engulfing
Consider long put target Δ ~0.70 · ~35 DTE Bearish setup, Grade A → ITM put target

Industry rank 21st of 22 in Drug Manufacturers - General

rescore-sweep
Technical synthesis
Bull 0%Evidence: High · 13 signals100% Bear
Momentum Bearish 12Mean-reversion Neutral 45

No notable composite patterns — the signals don't cluster into a named setup right now.

Where value comes from

Earnings power doesn't cover the capital structure (high debt) — the EPV decomposition isn't meaningful for this name.

Fundamentals Weak

0.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 35 metrics shown.

Strongest
Weakest
Greenblatt EY 0
Return on Capital Employed 0
Return on Assets 0

Technicals Bearish

6.0 / 100

Bearish setup leads (Rate of Change, Declining Volume, Engulfing); bulls gated by guards. · 43 signals shown.

Strongest
Weakest
Rate of Change 3
Declining Volume 11
Engulfing 15

Risk Gates

2 blocking 3 caution

2 guards active, 23 signals gated.

ADX Trend Weakness Blocking

Weak trend strength blocks trend-following signals in either direction.

Regime Filter Blocking

Blocks signals that oppose the long-term moving-average regime.

Altman Z-Score Caution

Bottom-band Altman Z blocks bullish signals — distress risk.

Sloan Ratio Caution

Visual accruals-quality flag — does not mute signals.

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for NSRX.